[go: up one dir, main page]

WO2003051227A3 - Feminine wipe for symptomatic treatment of vaginitis - Google Patents

Feminine wipe for symptomatic treatment of vaginitis Download PDF

Info

Publication number
WO2003051227A3
WO2003051227A3 PCT/US2002/038967 US0238967W WO03051227A3 WO 2003051227 A3 WO2003051227 A3 WO 2003051227A3 US 0238967 W US0238967 W US 0238967W WO 03051227 A3 WO03051227 A3 WO 03051227A3
Authority
WO
WIPO (PCT)
Prior art keywords
vaginitis
symptomatic treatment
feminine
wipe
feminine wipe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/038967
Other languages
French (fr)
Other versions
WO2003051227A2 (en
Inventor
Syed Rizvi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU2002362069A priority Critical patent/AU2002362069A1/en
Publication of WO2003051227A2 publication Critical patent/WO2003051227A2/en
Publication of WO2003051227A3 publication Critical patent/WO2003051227A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An article and method are described for treatment of vaginitis to inhibit bacterial growth and other odor causing and infectious organisms in the genital area. The composition is a liquid which conveniently is impregnated onto an absorbent substrate such as a fabric patch, which may be enclosed in a sealed envelope.
PCT/US2002/038967 2001-12-14 2002-12-06 Feminine wipe for symptomatic treatment of vaginitis Ceased WO2003051227A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002362069A AU2002362069A1 (en) 2001-12-14 2002-12-06 Feminine wipe for symptomatic treatment of vaginitis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33939901P 2001-12-14 2001-12-14
US60/339,399 2001-12-14

Publications (2)

Publication Number Publication Date
WO2003051227A2 WO2003051227A2 (en) 2003-06-26
WO2003051227A3 true WO2003051227A3 (en) 2004-01-08

Family

ID=23328823

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038967 Ceased WO2003051227A2 (en) 2001-12-14 2002-12-06 Feminine wipe for symptomatic treatment of vaginitis

Country Status (2)

Country Link
AU (1) AU2002362069A1 (en)
WO (1) WO2003051227A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1980241B1 (en) 2007-04-04 2015-10-14 Mibelle AG Wet wipes with vitex agnus castus extract for feminine personal care
US20110150955A1 (en) 2009-12-23 2011-06-23 Shannon Elizabeth Klingman Products and Methods for Reducing Malodor from the Pudendum
WO2011103183A1 (en) * 2010-02-16 2011-08-25 Playtex Products,Llc Low ph, optimal orp, and odor-reducing fibers, a process for making the fibers, and articles made therefrom

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540408A (en) * 1981-04-30 1985-09-10 Smith And Nephew Associated Companies Limited Applicators for pharmacologically active agents, their preparation and use
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
US6156323A (en) * 1995-06-08 2000-12-05 Johnson & Johnson Consumer Companies, Inc. Tricot-like pouch for the delivery of topical drugs and cosmetics
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6313159B1 (en) * 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
US6319510B1 (en) * 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
US6328991B1 (en) * 1992-10-21 2001-12-11 John Myhling Composition and method for prevention of sexually transmitted diseases, including aids
US6346263B1 (en) * 1996-09-27 2002-02-12 Sarl Kappa Biotech Biodegradable ionic matrix of variable internal polarity with grafted polymer

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540408A (en) * 1981-04-30 1985-09-10 Smith And Nephew Associated Companies Limited Applicators for pharmacologically active agents, their preparation and use
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US6328991B1 (en) * 1992-10-21 2001-12-11 John Myhling Composition and method for prevention of sexually transmitted diseases, including aids
US6156323A (en) * 1995-06-08 2000-12-05 Johnson & Johnson Consumer Companies, Inc. Tricot-like pouch for the delivery of topical drugs and cosmetics
US6346263B1 (en) * 1996-09-27 2002-02-12 Sarl Kappa Biotech Biodegradable ionic matrix of variable internal polarity with grafted polymer
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6319510B1 (en) * 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
US6313159B1 (en) * 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors

Also Published As

Publication number Publication date
AU2002362069A1 (en) 2003-06-30
WO2003051227A2 (en) 2003-06-26
AU2002362069A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
CA2415272A1 (en) Improvements in and relating to the use of honey in dressings
WO2002076339A3 (en) Absorbent article having hydrophobic leak protection zones
AU2001229925A1 (en) Antimicrobial flash-dry disinfectant aerosol
CA2305739A1 (en) Product and preparation containing lactic acid bacteria
MY128865A (en) Absorbent article having a reduced viability of candida albicans
WO2006052839A3 (en) Vacuum wound dressing
AU2002235146A1 (en) Non-thermionic sputter material transport device, methods of use, and materials produced thereby
SG94784A1 (en) Porous sheet, absorbent article using porous sheet and manufacturing method thereof
AU2001236973A1 (en) Absorbent article with thermal cell
CA2405370A1 (en) Fibrous absorbent articles having malodor counteractant ability and method of making same
WO2001008620A3 (en) Absorbent article which maintains skin temperature when wet
WO2001064033A3 (en) Hydratable form of keratin for use as a soil amendment
CA2464389A1 (en) Substance delivery device
EP1190724B8 (en) Use of antifibrinolytic agents for preparing sponges, compresses or dressings
WO2003064755A3 (en) Aqueous odor control composition
EP1104450A4 (en) A cleaning solution and method
EP1133979A3 (en) Use of specific fatty compounds for modifying the physico-chemical properties of the skin and/or the mucous membrane as agents for preventing or reducing the adhesion of micro-organisms thereon
WO2002030477A8 (en) Use of n-halamine biocidal polymer for odor control
WO2003051227A3 (en) Feminine wipe for symptomatic treatment of vaginitis
AU6908700A (en) Soft, absorbent material for use in absorbent articles and process for making the same
EP0937776A3 (en) Immobilized enzymes
IL138183A0 (en) Ph reducing formulation and delivery system for a tampon
WO2001076593A3 (en) Bile secretion promoting composition a 15-keto prostaglandin
AU2001286839A1 (en) Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same
AU2001276360A1 (en) Method for the antimicrobial treatment of material likely to be infested with microbes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP